Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2015 1:18:58 GMT -5
Per sanofi and Nasdaq websites
|
|
|
|
Post by bradleysbest on Feb 3, 2015 1:33:02 GMT -5
Per Yahoo , industry analysts project modest sales of 182 million a year by 2019! We should surpass that easily.....
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2015 1:34:42 GMT -5
Per Yahoo , industry analysts project modest sales of 182 million a year by 2019! We should surpass that easily..... That number has been floated out there by short analysts for a bit. You want that number nice and low. |
|
|
|
Post by bion61 on Feb 3, 2015 1:35:03 GMT -5
|
|
|
|
Post by babaoriley on Feb 3, 2015 2:09:47 GMT -5
Per Yahoo , industry analysts project modest sales of 182 million a year by 2019! We should surpass that easily..... That would be beyond disastrous! Modest sales by 2019 would be about $2 billion. |
|
|
|
Post by itrade on Feb 3, 2015 3:04:09 GMT -5
Well........
CONGRATULATIONS EVERYONE!!!!
This is a moment in which EVERY investor in MNKD should be proud of!!
"That's one small step for man (shorts), one giant leap for MannKind (longs & diabetics)" 
|
|
|
|
Post by liane on Feb 3, 2015 6:22:43 GMT -5
|
|
|
|
Post by savzak on Feb 3, 2015 6:29:51 GMT -5
Once again, all SNY comments focus on the fact that it is not injected. |
|
|
|
Post by liane on Feb 3, 2015 7:19:14 GMT -5
|
|
|
|
Post by savzak on Feb 3, 2015 7:55:00 GMT -5
The B Roll is apparently the embedded video. The casting call we saw a few weeks ago must've been for this video. There is audio of the monologue, but I heard nothing during the demo part of the video. |
|
|
|
Post by notamnkdmillionaire on Feb 3, 2015 7:55:13 GMT -5
I was like this when I saw the news  |
|
|
|
Post by pmikeks on Feb 3, 2015 8:02:17 GMT -5
SA looks to combine announcement with a soft hit piece. "Afrezza is priced at $7.54 for a daily dose of 12 units compared to $3.14 for SNY injectable Apidra" . They used the maximum dose of Aftezza and didn't compare to the cost of using a pen. I'd be happy to pay $226 a month rather then the $320 a month I pay for Lantus. They follow that with a rediculous sales projection by 2019 that should be achieved by July this year.
SNY could make things a lot better for us if they would provide a reasonable estimate of sales rather then adopting Mannkind's stance of non-communication.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Feb 3, 2015 8:14:32 GMT -5
Once again, all SNY comments focus on the fact that it is not injected. Why shouldn't it? The end consumer wants a simple message. We know much more and this point continues to be argued. Do you think SNY is running out telling doctors to use it because it's not injected? Just because the general population doesn't see the message doesn't mean it's not being utilized. Pks are a big part, but not for everyone, imo. |
|
|
|
Post by rak5555 on Feb 3, 2015 8:35:28 GMT -5
Once again, all SNY comments focus on the fact that it is not injected. Why shouldn't it? The end consumer wants a simple message. We know much more and this point continues to be argued. Do you think SNY is running out telling doctors to use it because it's not injected? Just because the general population doesn't see the message doesn't mean it's not being utilized. Pks are a big part, but not for everyone, imo. Fug - I completely agree re: simple message, plus a lot of what SNY would like to say did not make the label. And further, SNY has done a very good job keeping their co mpetition in the dark, so why would they emphasize the selling points they are going to use when selling to the docs? |
|
|
|
Post by cybergym66 on Feb 3, 2015 8:41:36 GMT -5
Once again, all SNY comments focus on the fact that it is not injected. Why shouldn't it? The end consumer wants a simple message. We know much more and this point continues to be argued. Do you think SNY is running out telling doctors to use it because it's not injected? Just because the general population doesn't see the message doesn't mean it's not being utilized. Pks are a big part, but not for everyone, imo. I get what Savzak is saying...SNY is leaving a lot of benefits of Afrezza untold. Look at Afrezzuser's comments...he's WAY more focused on his sugar numbers and could care less about Afrezza being inhaled vs injected (in terms of delivery). He LOVES the benefits of Afrezza and that it controls his sugar levels which the injectables didn't. His comments is that Afrezza makes him feel like a NORMAL person!!! Big benefit of Afrezza! And he has zero worries about having a low and he LOVES the soft curves of his sugar readings. His Lantus readings were jagged/spikey. So focusing on "no more needles (which isn't completely true)" is really selling Afrezza short. |
|
